Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142

This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Director, Massachusetts Host-Microbiome Center
Dr. Bry Directs the Massachusetts Host-Microbiome Center and has held a longstanding interest in host-commensal interactions, particularly through using genetically tenable microbes to probe host responses. Her group actively develops commensal microbial consortia for experimental and clinical applications, including therapeutic uses as immunomodulators, and to provide defenses against gut pathogens. In addition, she oversees a multi-institutional pathogen genomic sequencing program that monitors genomic causes of multi-drug resistance in patient isolates. The program was the first CLIA lab to join the FDA GenomeTrakr program and has developed real-time sequencing and functional studies to define host range and risks for pathogen transmission in carbapenem-resistant Enterobacteriaceae (CRE) through to dynamics of Clostridium difficile infection in hospitalized patients. Dr. Bry did her undergraduate work at Cornell University, studying classical bacterial genetics in Bacillus subtitles. She completed medical and graduate work in the Department of Molecular Microbiology and Pathogenesis at Washington University in St. Louis and was the first microbiology student to work in Dr. Jeffery Gordon’s laboratory, developing the host-microbial symbiotic model between Bacteroides thetaiotaomicron and its capacity to induce gut epithelial fucosyltransfases. After completing the Clinical Pathology residency program at Brigham & Women’s Hospital, she was awarded a Howard Hughes Medical Institute fellowship to study mucosal immunology in the laboratory of Dr. Michael Brenner where she defined mucosal and systemic immune responses needed to control infections with attaching and effacing pathogens.

Brought to you by